|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2004-8-17
|
|
pubmed:abstractText |
Considerable variability exists in the use of pharmacological thromboprophylaxis among acutely ill medical patients, partly because clinically relevant end points have not been fully assessed in this population. We undertook an international, multicenter, randomized, double-blind, placebo-controlled trial using clinically important outcomes to assess the efficacy and safety of dalteparin in the prevention of venous thromboembolism in such patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
17
|
|
pubmed:volume |
110
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
874-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15289368-Acute Disease,
pubmed-meshheading:15289368-Adult,
pubmed-meshheading:15289368-Aged,
pubmed-meshheading:15289368-Aged, 80 and over,
pubmed-meshheading:15289368-Anticoagulants,
pubmed-meshheading:15289368-Dalteparin,
pubmed-meshheading:15289368-Death, Sudden,
pubmed-meshheading:15289368-Double-Blind Method,
pubmed-meshheading:15289368-Female,
pubmed-meshheading:15289368-Hemorrhage,
pubmed-meshheading:15289368-Hospital Mortality,
pubmed-meshheading:15289368-Humans,
pubmed-meshheading:15289368-Immobilization,
pubmed-meshheading:15289368-Incidence,
pubmed-meshheading:15289368-Male,
pubmed-meshheading:15289368-Middle Aged,
pubmed-meshheading:15289368-Pulmonary Embolism,
pubmed-meshheading:15289368-Risk,
pubmed-meshheading:15289368-Thromboembolism,
pubmed-meshheading:15289368-Thrombophilia,
pubmed-meshheading:15289368-Treatment Outcome,
pubmed-meshheading:15289368-Venous Thrombosis
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
|
|
pubmed:affiliation |
Unité de Pharmacologie Clinique, Université Claude Bernard Lyon I, Lyon, France. al@upcl.univ-lyon1.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
